Selenium levels in serum, red blood cells, and cerebrospinal fluid of Alzheimer's disease patients

a report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)

Bárbara R. Cardoso*, Dominic J. Hare, Ashley I. Bush, Qiao Xin Li, Christopher J. Fowler, Colin L. Masters, Ralph N. Martins, Katherine Ganio, Amber Lothian, Soumya Mukherjee, Eugene A. Kapp, Blaine R. Roberts, The AIBL Research Group

*Corresponding author for this work

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Selenium (Se) protects cells against oxidative stress damage through a range of bioactive selenoproteins. Increased oxidative stress is a prominent feature of Alzheimer's disease (AD), and previous studies have shown that Se deficiency is associated with age-related cognitive decline. In this study, we assessed Se status in different biofluids from a subgroup of participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. As Se in humans can either be an active component of selenoproteins or inactive via non-specific incorporation into other proteins, we used both size exclusion chromatography-inductively coupled plasma-mass spectrometry (SEC-ICP-MS) and tandem mass spectrometry to characterize selenoproteins in serum. We observed no differences in total Se concentration in serum or cerebrospinal fluid of AD subjects compared to mildly cognitively impairment patients and healthy controls. However, Se levels in erythrocytes were decreased in AD compared to controls. SEC-ICP-MS analysis revealed a dominant Se-containing fraction. This fraction was subjected to standard protein purification and a bottom-up proteomics approach to confirm that the abundant Se in the fraction was due, in part, to selenoprotein P. The lack of change in the Se level is at odds with our previous observations in a Brazilian population deficient in Se, and we attribute this to the Australian cohort being Se-replete.

Original languageEnglish
Pages (from-to)183-193
Number of pages11
JournalJournal of Alzheimer's Disease
Volume57
Issue number1
DOIs
Publication statusPublished - 2017
Externally publishedYes

Keywords

  • Alzheimer's disease
  • cognition
  • selenium
  • selenocysteine
  • selenoproteins

Fingerprint Dive into the research topics of 'Selenium levels in serum, red blood cells, and cerebrospinal fluid of Alzheimer's disease patients: a report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)'. Together they form a unique fingerprint.

  • Cite this